Distinguishing Between Off-Label Guidelines for Device vs. Pharmaceutical Companies
July 14, 2010
David Rosen will present, “Distinguishing Between Off-Label Guidelines for Device vs. Pharmaceutical Companies” at the ACI 7th National Forum on Off-Label Communications, July 14-15, 2010 at the Union League, in Philadelphia.
Speakers will cover compliance strategies with FDA off-label promotion guidelines, training physicians on the use of medical devices, and learning from device manufacturers’ litigation. Thomas Lynch, Senior Corporate Counsel at Boston Scientific will join Mr. Rosen as a speaker.
More information can be found on ACI’s Web site.
People
Related Insights
July 2, 2025
Energy Current
Has SCOTUS Pre-decided Whether the NRC Can License Private Off-Site High-Level Nuclear Waste Storage Facilities?
On June 18, 2025, the U.S. Supreme Court, in NRC v. Texas, issued an opinion holding that the State of Texas did not have standing to…
July 2, 2025
Health Care Law Today
AI-Powered Text Messaging by Digital Health Companies: Supreme Court Raises the Stakes
Digital health companies increasingly rely on AI-powered messaging platforms, chatbots, and virtual assistants to engage patients through…
July 2, 2025
Innovative Technology Insights
AI-Powered Text Messaging by Digital Health Companies: Supreme Court Raises the Stakes
Digital health companies increasingly rely on AI-powered messaging platforms, chatbots, and virtual assistants to engage patients through…